Document Detail


Why does thrombolysis fail? Breaking through the reperfusion ceiling.
MedLine Citation:
PMID:  9416941     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
With best current regimens, thrombolysis may initially fail in 15% to 40% of cases because of hemodynamic or mechanical factors, inadequate fibrinolysis, or failure to lyse platelet-rich thrombi. Pathophysiologic considerations and early experimental and clinical trials suggest that improved conjunctive antiplatelet therapy (as with glycoprotein IIb/IIIa inhibitors) and, possibly, more effective antithrombins (low molecular weight heparins, hirudin) may allow this thrombolysis "ceiling" to be broken and the goal achieved of reperfusion rates closer to those of primary angioplasty.
Authors:
J L Anderson
Publication Detail:
Type:  Editorial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  80     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1997 Dec 
Date Detail:
Created Date:  1998-01-20     Completed Date:  1998-01-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1588-90     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Humans
Myocardial Infarction / drug therapy*
Myocardial Reperfusion Injury / etiology
Thrombolytic Therapy* / adverse effects
Treatment Failure

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiop...
Next Document:  Short-term (4 hours) observation after elective coronary angioplasty.